Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADYNOVATE in Previously Untreated Children With Severe Hemophilia A
NCT02615691Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2015
- Primary completion
- Oct 2024
- Countries
- 23
01
Overview
A Phase 3 trial of recombinant coagulation factor viii in hemophilia A, sponsored by Takeda. Started Nov 2015; status: completed.
02
Drugs
recombinant coagulation factor viii
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02615691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615691.